scispace - formally typeset
Open AccessJournal ArticleDOI

SARS-CoV-2: a storm is raging.

Savannah F. Pedersen, +1 more
- 01 May 2020 - 
- Vol. 130, Iss: 5, pp 2202-2205
TLDR
Overall, this study characterized the cytokine storm in severe COVID-19 and provides insights into immune therapeutics and vaccine design and the authors found that respiratory distress on admission is associated with unfavorable outcomes.
Abstract
The pandemic coronavirus infectious disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly spreading across the globe. In this issue of the JCI, Chen and colleagues compared the clinical and immunological characteristics between moderate and severe COVID-19. The authors found that respiratory distress on admission is associated with unfavorable outcomes. Increased cytokine levels (IL-6, IL-10, and TNF-α), lymphopenia (in CD4+ and CD8+ T cells), and decreased IFN-γ expression in CD4+ T cells are associated with severe COVID-19. Overall, this study characterized the cytokine storm in severe COVID-19 and provides insights into immune therapeutics and vaccine design.

read more

Citations
More filters
Journal ArticleDOI

Herd-immunity against COVID-19: Is it enough to stop a second wave?

TL;DR: Many reports doubt the efficacy and durability of the “post-infection” immunity, therefore, countries should not rely on herd-immunity for protection against the further-coming wave of COVID-19.
Journal ArticleDOI

Pregnancy-specific responses to COVID-19 are revealed by high-throughput proteomics of human plasma

TL;DR: In this paper , a comprehensive characterization of the plasma proteome of pregnant and non-pregnant COVID-19 patients was performed using the SOMAmer platform, which revealed that pregnant women display a tailored response that may protect the conceptus from heightened inflammation, while non-Pregnant individuals display a stronger response to repel infection.
Journal ArticleDOI

Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines.

TL;DR: This review mainly focused on promising candidates for the treatment of COVID-19 and collected recently updated evidence relevant to its feasibility in clinical practice in the near future.
Journal ArticleDOI

Infekcija SARS-CoV-2 (COVID-19) u djece

TL;DR: A pandemija uzrokovana SARS-om -CoV-2 veliki je javnozdravstveni problem u svim zemljama svijeta as discussed by the authors.
Journal ArticleDOI

TRPC3-Nox2 Protein Complex Formation Increases the Risk of SARS-CoV-2 Spike Protein-Induced Cardiomyocyte Dysfunction through ACE2 Upregulation

TL;DR: In this paper , ibudilast, which was previously identified as a potent inhibitor of protein complex between transient receptor potential canonical (TRPC) 3 and NADPH oxidase (Nox) 2, attenuates the SARS-CoV-2 spike glycoprotein pseudovirus-evoked contractile and metabolic dysfunctions of neonatal rat cardiomyocytes (NRCMs).
References
More filters
Journal ArticleDOI

A Novel Coronavirus from Patients with Pneumonia in China, 2019.

TL;DR: Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily, which is the seventh member of the family of coronaviruses that infect humans.
Related Papers (5)